Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: Interactive Journal of Medical Research (no longer under consideration since Oct 01, 2024)

Date Submitted: May 18, 2024
Open Peer Review Period: May 28, 2024 - Jul 23, 2024
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

CRITICAL REVIEW OF THE DIAGNOSTIC AND STATISTICAL SUPPORT FOR COVID EPIDEMIC IN USA

  • Jan Charles Biro

ABSTRACT

Background:

Two major flaws have been identified in collecting and interpreting the COVID epidemic data. 1) The United States ignored the International Guidelines for Certification and Classification (Coding) of COVID-19 as Cause of Death (20 April 2020 – WHO). The Guidelines suggested the use of U07.1 code for virus identified (certain) and U07.2 code for virus not identified (suspected but not objectively confirmed) cases of deaths. The American statistic used exclusively the U07.1 code causing confusion and endless disputes about the accuracy of COVID mortality estimates in this country. 2) Large number of natural, age related, expected deaths have been reported as COVID related deaths even if the virus reasonably couldn’t play any causative role as the Underlying Cause of Death (UCOD).

Objective:

A statistical method is suggested 1) to estimate the realistic proportion of test-confirmed COVID mortality relative to the less well confirmed causes of COVID deaths there viral-test is missing; 2) to estimate the number of seniors who could have passed away ‘with’ COVID but not ‘because’ of COVID infection. 1) The estimated maximal possible number of test-confirmed (true) cases of COVID deaths was based on the frequency of viral-test positivity in the population. It was possible because epidemiological studies indicated even distribution of infection in all categories of the persons in the entire population. 2) The age-normalized annual mortality (from actuarial tables) gives an idea how many persons could have died “normally” even without the COVID epidemic.

Methods:

1) The estimated maximal possible number of test-confirmed (true) cases of COVID deaths was based on the frequency of viral-test positivity in the population. It was possible because epidemiological studies indicated even distribution of infection in all categories of the persons in the entire population. 2) The age-normalized annual mortality (from actuarial tables) gives an idea how many persons could have died “normally” even without the COVID epidemic.

Results:

1) COVID as the Underlying Cause of Death (UCOD) haven’t been verified by specific laboratory viral test in ca. 40.3% of reported causes. These, exclusively HEARSAY information based cases violated the WHO guidelines for reporting COVID related deaths. (Use of U07.1 code). 2) Large number of natural, age related, expected deaths have been reported as COVID related deaths even if the virus reasonably couldn’t play any causative role as UCOD. These PSEUDO COVID deaths were ca 46% of all reported COVID deaths. The oldest persons in this group were 85+ years old and comprised as much as 28% to all allegedly COVID fatalities (the GERONTO COVID deaths). These errors significantly inflated the number of COVID deaths and the related mortality statistic.

Conclusions:

The number of correctly identified COVID related deaths in our study is about 32% of the officially published number [171K instead of 533K, respectively]. The average FATALITY of COVID stays at ~0.54% and the MORTALITY 53/100K. (On May 2021).


 Citation

Please cite as:

Biro JC

CRITICAL REVIEW OF THE DIAGNOSTIC AND STATISTICAL SUPPORT FOR COVID EPIDEMIC IN USA

JMIR Preprints. 18/05/2024:60679

DOI: 10.2196/preprints.60679

URL: https://preprints.jmir.org/preprint/60679

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.